Mrs Ponnamma G Kaimulayil, | |
75 Tanglewood Dr, East Hanover, NJ 07936-3306 | |
(973) 585-4000 | |
Not Available |
Full Name | Mrs Ponnamma G Kaimulayil |
---|---|
Gender | Female |
Speciality | Registered Nurse |
Location | 75 Tanglewood Dr, East Hanover, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609050459 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | 26NR08565100 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Ponnamma G Kaimulayil, 75 Tanglewood Dr, East Hanover, NJ 07936-3306 Ph: (973) 585-4000 | Mrs Ponnamma G Kaimulayil, 75 Tanglewood Dr, East Hanover, NJ 07936-3306 Ph: (973) 585-4000 |
News Archive
Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks) for its lead product candidate, A-002, an oral sPLA2 inhibitor, in combination with HMG-CoA reductase inhibitor, or statin, therapy for short-term (16-week) treatment of patients experiencing an acute coronary syndrome.
About 80% of stroke survivors experience hemiparesis, which causes weakness or the inability to move one side of the body. Core stabilization exercise to improve postural stability and independent walking in chronic hemiparetic stroke patients could be enhanced by real-time video feedback, report researchers in Restorative Neurology and Neuroscience.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, together with its international commercialization partners, today announced that enrollment has been initiated and the first patient has been randomized in a Phase 2b clinical trial called TRAVERSE.
Even the briefest increase in airborne fine particulate matter PM2.5, pollution-causing particles that are about 3 percent of the diameter of human hair, is associated with the development of acute lower respiratory infection (ALRI) in young children, according to newly published research.
› Verified 9 days ago
Susan Begic, NP-C Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 383 Ridgedale Ave, East Hanover, NJ 07936 Phone: 973-887-0200 Fax: 973-887-4965 | |
Mrs. Mary Theresa Downey-freiman, RN MSN OCN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Health Plz, East Hanover, NJ 07936 Phone: 862-778-8300 |